2,4-Dienoyl-CoA reductase deficiency
Alternate names[edit]
Dienoyl-CoA reductase deficiency; 2,4-alpha dienoyl-CoA reductase deficiency
Definition[edit]
2,4-Dienoyl-CoA reductase deficiency is associated with hypotonia and respiratory acidosis in infancy. This is an inherited (genetic) condition that prevents your baby’s body from breaking down certain fats and turning them into energy. If your baby does not make enough energy from fat, substances build up in the blood and can cause serious health problems.
Epidemiology[edit]
There have only been two reported cases of DE-RED.
Cause[edit]
- This condition may be associated with the DECR1 gene.
- This gene gives the body instructions for making an enzyme that breaks down a certain type of fat, called “unsaturated fatty acids.”
Gene mutations[edit]
- When a change in the NADK2 gene causes it to not work, the body cannot properly break down fat to make energy.
- This leads to the signs and symptoms of the condition.
Inheritance[edit]

This condition has autosomal recessive pattern of inheritance.
Signs and symptoms[edit]
There have only been two reported cases of DE-RED. In both cases, signs of the condition were present from birth.
Signs of the condition in the two known cases have included the following:
- Poor feeding
- Small head size (microcephaly)
- Weak muscle tone (hypotonia)
- Vomiting
- Gets upset easily
- Delays in weight gain
- Breathing problems
Diagnosis[edit]
- Newborn screening for DE-RED is done using a small amount of blood collected from your baby’s heel.
- During screening, a special machine measures how much of certain substances (called acylcarnitines) are in your baby’s blood.
- The body produces these substances when it makes energy from fats.
- Babies with high levels of these substances might have DE-RED.
Treatment[edit]
management of this conition may include:
| Inborn error of lipid metabolism: fatty-acid metabolism disorders | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info[edit]
2,4-Dienoyl-CoA reductase deficiency is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - 2,4-Dienoyl-CoA reductase deficiency
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


